KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Other Working Capital Changes (2018 - 2025)

Esperion Therapeutics' Other Working Capital Changes history spans 8 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 137.19% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $26.0 million, changed N/A, while the annual FY2025 figure was $26.0 million, N/A changed from the prior year.
  • Other Working Capital Changes reached $3.8 million in Q4 2025 per ESPR's latest filing, down from $14.7 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $23.5 million in Q4 2023 to a low of -$12.4 million in Q2 2023.
  • Average Other Working Capital Changes over 5 years is $2.6 million, with a median of $887500.0 recorded in 2021.
  • The largest YoY upside for Other Working Capital Changes was 4627.22% in 2023 against a maximum downside of 3836.94% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $5.8 million in 2021, then crashed by 109.01% to -$518000.0 in 2022, then skyrocketed by 4627.22% to $23.5 million in 2023, then plummeted by 143.55% to -$10.2 million in 2024, then soared by 137.19% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for ESPR's Other Working Capital Changes are $3.8 million (Q4 2025), $14.7 million (Q3 2025), and $11.4 million (Q2 2025).